ES396219A1 - Un metodo para preparar 2,4-diamino-5-bencilpirimidinas. - Google Patents

Un metodo para preparar 2,4-diamino-5-bencilpirimidinas.

Info

Publication number
ES396219A1
ES396219A1 ES396219A ES396219A ES396219A1 ES 396219 A1 ES396219 A1 ES 396219A1 ES 396219 A ES396219 A ES 396219A ES 396219 A ES396219 A ES 396219A ES 396219 A1 ES396219 A1 ES 396219A1
Authority
ES
Spain
Prior art keywords
group
formula
compound
represent
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES396219A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES396219A1 publication Critical patent/ES396219A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES396219A 1970-10-22 1971-10-21 Un metodo para preparar 2,4-diamino-5-bencilpirimidinas. Expired ES396219A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB963871*[A GB1375162A (zh) 1970-10-22 1970-10-22
GB963871 1971-04-16
GB4749171 1971-10-12

Publications (1)

Publication Number Publication Date
ES396219A1 true ES396219A1 (es) 1975-09-16

Family

ID=27255400

Family Applications (1)

Application Number Title Priority Date Filing Date
ES396219A Expired ES396219A1 (es) 1970-10-22 1971-10-21 Un metodo para preparar 2,4-diamino-5-bencilpirimidinas.

Country Status (20)

Country Link
JP (2) JPS5536662B1 (zh)
AR (3) AR192588A1 (zh)
AT (1) AT319948B (zh)
BE (1) BE774281A (zh)
BG (4) BG20364A3 (zh)
CA (1) CA967158A (zh)
CH (3) CH568301A5 (zh)
DD (1) DD100877A5 (zh)
DK (1) DK132174C (zh)
ES (1) ES396219A1 (zh)
FI (1) FI56175C (zh)
FR (1) FR2111769B1 (zh)
GB (1) GB1375162A (zh)
IE (1) IE37452B1 (zh)
IL (2) IL45422A (zh)
LU (1) LU64129A1 (zh)
MC (1) MC894A1 (zh)
NL (1) NL175178C (zh)
SE (2) SE384505B (zh)
ZM (1) ZM14971A1 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
FR2397407A2 (fr) * 1977-07-11 1979-02-09 Dick Pierre Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides
MA18450A1 (fr) * 1978-05-24 1979-12-31 Wellcome Found Composition de benzylpirimidines
JPS61156909A (ja) * 1984-12-27 1986-07-16 Matsushita Electric Ind Co Ltd カレント・ミラ−回路
JPS62145907A (ja) * 1985-12-20 1987-06-30 Hitachi Ltd トランジスタ回路
ES2563952T3 (es) 2004-03-26 2016-03-16 Sumitomo Dainippon Pharma Co., Ltd. Compuesto de 8-oxoadenina 9-sustituido
JP2009542645A (ja) 2006-07-05 2009-12-03 アストラゼネカ・アクチエボラーグ Tlr7のモジュレーターとして作用する8−オキソアデニン誘導体
TW200831105A (en) 2006-12-14 2008-08-01 Astrazeneca Ab Novel compounds
DK2132209T3 (da) 2007-03-19 2014-04-14 Astrazeneca Ab 9-substituerede 8-oxo-adeninforbindelser som modulatorer af tlr7 (toll-like receptor 7)
WO2008114006A1 (en) 2007-03-19 2008-09-25 Astrazeneca Ab 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
EP2138497A4 (en) 2007-03-20 2012-01-04 Dainippon Sumitomo Pharma Co NEW ADENINE CONNECTION
PE20091236A1 (es) * 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
PE20091156A1 (es) 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
JP5913093B2 (ja) 2009-05-21 2016-04-27 アストラゼネカ アクチボラグ 新規ピリミジン誘導体と、癌とさらなる疾患の治療におけるそれらの使用
GB0908772D0 (en) 2009-05-21 2009-07-01 Astrazeneca Ab New salts 756
CN103370317B (zh) 2010-12-16 2015-10-07 阿斯利康(瑞典)有限公司 可用于治疗的咪唑并[4,5-c]喹啉-1-基衍生物
DK2651943T3 (en) 2010-12-17 2017-06-06 Sumitomo Dainippon Pharma Co Ltd purine derivatives
MY178053A (en) 2012-05-18 2020-09-30 Sumitomo Dainippon Pharma Co Ltd Carboxylic acid compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE710100A (zh) * 1967-02-02 1968-07-30
JPS511716A (ja) * 1974-06-25 1976-01-08 Toray Industries Horiesuterumaruchifuiramentono seiho

Also Published As

Publication number Publication date
IL45422A (en) 1976-03-31
SE384505B (sv) 1976-05-10
MC894A1 (fr) 1972-06-22
CH568301A5 (zh) 1975-10-31
AR192588A1 (es) 1973-02-28
CH582681A5 (zh) 1976-12-15
NL7114494A (zh) 1972-04-25
IE37452B1 (en) 1977-08-03
FR2111769B1 (zh) 1974-10-18
BG21406A3 (bg) 1976-05-20
DK132174C (da) 1976-03-29
CA967158A (en) 1975-05-06
AR192802A1 (es) 1973-03-14
NL175178C (nl) 1984-10-01
AT319948B (de) 1975-01-10
BE774281A (fr) 1972-04-21
LU64129A1 (zh) 1972-06-28
BG20365A3 (bg) 1975-11-05
FR2111769A1 (zh) 1972-06-09
SE409705B (sv) 1979-09-03
IL37984A0 (en) 1971-12-29
JPS53135991A (en) 1978-11-28
DK132174B (da) 1975-11-03
NL175178B (nl) 1984-05-01
ZM14971A1 (en) 1972-07-21
IE37452L (en) 1972-04-22
DD100877A5 (zh) 1973-10-12
JPS5536662B1 (zh) 1980-09-22
FI56175C (fi) 1979-12-10
CH568302A5 (zh) 1975-10-31
BG20364A3 (bg) 1975-11-05
AR192803A1 (es) 1973-03-14
BG20797A3 (bg) 1975-12-20
GB1375162A (zh) 1974-11-27
IL37984A (en) 1976-03-31
FI56175B (fi) 1979-08-31

Similar Documents

Publication Publication Date Title
ES396219A1 (es) Un metodo para preparar 2,4-diamino-5-bencilpirimidinas.
ES399497A1 (es) Procedimiento para la obtencion de p-mentano - 3 - carbosa-midas n - sustituidas.
ES477741A1 (es) Un procedimiento para preparar derivados de acido acetico.
ES386068A1 (es) Nuevo compuestos quimicos caracterizados por el hecho de estar constituidos por el acido fenil-5 isozazol carboxili- co-3 y sus derivados.
ES390778A1 (es) Un procedimiento para la fabricacion de fenilaminoalcanos.
ES367451A1 (es) Procedimiento para preparar i-glicosil-5-azacitosinas.
GB1369386A (en) Glycidyl-urethane compounds processes for their manufacture and their use
ES301365A1 (es) Un método para la preparación de un compuesto diurético
ES274330A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,5-benzodioxepano
ES272262A2 (es) Procedimiento de fabricación de nuevos tintes monoazoicos
ES383467A1 (es) Procedimiento para la preparacion de derivados de pirrol.
ES407133A1 (es) Un metodo para la produccion de derivados de dibenzoxirena-zepina.
ES313320A1 (es) Procedimiento para la obtencion de nuevos compuestos pirimidinicos.
ES439058A1 (es) Procedimiento para la preparacion de uretanos aromaticos.
ES451084A1 (es) Procedimiento para preparar compuestos monoazoicos.
ES247984A1 (es) Un procedimiento para preparar compuestospiperazinicos
ES247032A1 (es) Un procedimiento de preparar fenialcohoilhidrazinas
ES292201A1 (es) Método para la preparación de nuevos compuestos heterocíclicos de nitrofurilvinilo
ES362636A1 (es) Procedimiento para la preparacion de nuevos compuestos de n,n'-diglicidilo heterociclicos binucleares.
ES353247A1 (es) Un metodo para preparar un derivado de sidnona.
ES290281A1 (es) Procedimiento para el apresto o acabado antiestatico de compuestos organicos de elevado peso molecular
ES342431A1 (es) Procedimiento para preparar nuevas tetrahidro-1,3,5-tiadi- zin-2-tionas.
ES246717A1 (es) Un método de preparar nuevos compuestos de la serie de la tetraciclina
ES294616A1 (es) Un procedimiento para la fabricación de tintes azoicos hidrosolubles
ES367793A1 (es) Un procedimiento para preparar i-glicosil-5-azacitosinas.